Daiichi Sankyo, AstraZeneca sign $6.9 billion cancer drug deal

AstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer drug trastuzumab deruxtecan.

from Reuters: Health News https://ift.tt/2HYGXDQ
via IFTTT